In Cohort II, where disease activity measures were available, RA‐ILD patients similarly exhibited higher calprotectin after adjustment for DAS28‐CRP and/or PGA (adjusted geometric mean ratios 2.1–2.8, all p < 0.02; Table S2). This evidence concerns the gene CRP and rheumatoid arthritis.